Ezetimibe Impurity 41
 
		Product Description
CAT No.
				
									ALN-E026094								
				CAS No.
				
									1354716-94-1								
				Mol. F.
				
									C23H28FNO4Si								
				Mol. Wt.
				
									429.6								
				Stock
				
									Please Inquire								
				
										
							
										Product Overview
						
											
										
							
										Technical Data
						
											
										
							
										Reference
						
											
										
							
										RFQ
						
									
							
							
							Product Overview
			
						
									Chemical Name : (S)-3-((S)-5-(4-Fluorophenyl)-5-((trimethylsilyl)oxy)pentanoyl)-4-phenyloxazolidin-2-one								
				
									Smiles : O=C1OC[C@H](C2=CC=CC=C2)N1C(CCC[C@@H](C3=CC=C(F)C=C3)O[Si](C)(C)C)=O								
				
									Inchi : InChI=1/C11H21N/c1-10(2)8-5-6-11(10,3)9(7-8)12-4/h8-9,12H,5-7H2,1-4H3								
				
							
							
							Technical Data
			
						
							
							
							Reference
			
						Related substances by HPLC method for the detection and evaluation of impurities in ezetimibe drug material
									By Rapeti, Durgababu; Reddy, Gudibanda Chandra Sekhar; Narayanarao, Kapavarapu Maruthi Venkata; Shyamala, Pulipaka; Krishna, Rallabhandi MuralinFrom International Journal of Pharmaceutical Sciences and Research (2021), 12(1), 217-225								
				Stability-indicating liquid chromatographic method for the simultaneous determination of rosuvastatin and ezetimibe from pharmaceuticals and biological samples
									By Kurbanoglu, Sevinc; Esim, Ozgur; Ozkan, Cansel Kose; Savaser, Ayhan; Ozkan, Yalcin; Uslu, Bengi; Ozkan, Sibel A. – From Journal of the Turkish Chemical Society, Section A: Chemistry (2020), 7(3), 865-874 								
				Stability-indicating analytical method development using quality by design approach for simultaneous estimation of ezetimibe and glimepiride
									By Shah, U.; Shah, Kunti; Patel, Rupal – From Indian Journal of Pharmaceutical Sciences (2019), 81(2), 273-281								
				
							
							
							RFQ
			
						
 
                             
                             
                             
                             
                            